Spaulding Clinical Research Reports Record Revenue for 2012
February 4, 2013 – West Bend, Wisconsin, USA Today, Spaulding Clinical Research, a change agent in the clinical research and medical device industries, announces that the company tripled its fiscal yearly revenues for the period ending December 31st, 2012. “Our customer retention and the ability to attract new Sponsors demonstrate Spaulding Clinical’s commitment to delivering the highest-quality, on-time study results for every study. This is also reflected in our high net promoter score,” states Daniel Selness, General Manager and Sr. Vice President of Clinical Research at Spaulding.